BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1239 related articles for article (PubMed ID: 16942566)

  • 21. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
    Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
    Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season.
    Wilson DR; Nouri-Aria KT; Walker SM; Pajno GB; O'Brien F; Jacobson MR; Mackay IS; Durham SR
    J Allergy Clin Immunol; 2001 Jun; 107(6):971-6. PubMed ID: 11398073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration.
    Antúnez C; Mayorga C; Corzo JL; Jurado A; Torres MJ
    Pediatr Allergy Immunol; 2008 May; 19(3):210-8. PubMed ID: 18399897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The T cell response to major grass allergens is regulated and includes IL-10 production in atopic but not in non-atopic subjects.
    Domdey A; Liu A; Millner A; Lund K; Jacobi H; Malling HJ; Søndergaard I; Würtzen PA
    Int Arch Allergy Immunol; 2010; 152(3):243-54. PubMed ID: 20150742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum transforming growth factor-beta levels depend on allergen exposure in allergic rhinitis.
    Ciprandi G; De Amici M; Tosca M; Marseglia G
    Int Arch Allergy Immunol; 2010; 152(1):66-70. PubMed ID: 19940507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential mRNA expression and production of interleukin-4 and interferon-gamma in stimulated peripheral blood mononuclear cells of house-dust mite-allergic patients.
    Laan MP; Baert MR; Vredendaal AE; Savelkoul HF
    Eur Cytokine Netw; 1998 Mar; 9(1):75-84. PubMed ID: 9613681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
    Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
    Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allergen-specific immunotherapy induces Th1 shift in dogs with atopic dermatitis.
    Shida M; Kadoya M; Park SJ; Nishifuji K; Momoi Y; Iwasaki T
    Vet Immunol Immunopathol; 2004 Nov; 102(1-2):19-31. PubMed ID: 15451612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The imbalance of Th1/Th2 cytokine expression in peripheral blood mononuclear cell from asthmatic patients and the effect of erythromycin on these cytokines].
    Xiao W; Yu H; Zheng C
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jun; 23(6):347-50. PubMed ID: 11778516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy, safety, and immunological effects of a 2-year immunotherapy with Depigoid birch pollen extract: a randomized, double-blind, placebo-controlled study.
    Höiby AS; Strand V; Robinson DS; Sager A; Rak S
    Clin Exp Allergy; 2010 Jul; 40(7):1062-70. PubMed ID: 20642579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGF-beta and IL-17 serum levels and specific immunotherapy.
    Ciprandi G; De Amici M; Negrini S; Marseglia G; Tosca MA
    Int Immunopharmacol; 2009 Sep; 9(10):1247-9. PubMed ID: 19622397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of Foxp3+ T cells in long-term efficacy of prophylactic and therapeutic mucosal tolerance induction in mice.
    Winkler B; Hufnagl K; Spittler A; Ploder M; Kállay E; Vrtala S; Valenta R; Kundi M; Renz H; Wiedermann U
    Allergy; 2006 Feb; 61(2):173-80. PubMed ID: 16409192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
    Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
    Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes.
    Keles S; Karakoc-Aydiner E; Ozen A; Izgi AG; Tevetoglu A; Akkoc T; Bahceciler NN; Barlan I
    J Allergy Clin Immunol; 2011 Oct; 128(4):808-815.e7. PubMed ID: 21641635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy.
    Nouri-Aria KT; Pilette C; Jacobson MR; Watanabe H; Durham SR
    J Allergy Clin Immunol; 2005 Jul; 116(1):73-9. PubMed ID: 15990777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
    Masuyama K; Jacobson MR; Rak S; Meng Q; Sudderick RM; Kay AB; Lowhagen O; Hamid Q; Durham SR
    Immunology; 1994 Jun; 82(2):192-9. PubMed ID: 7927488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of Cordyceps extract on cytokines and transcription factors in peripheral blood mononuclear cells of asthmatic children during remission stage].
    Sun W; Yu J; Shi YM; Zhang H; Wang Y; Wu BB
    Zhong Xi Yi Jie He Xue Bao; 2010 Apr; 8(4):341-6. PubMed ID: 20388474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration.
    Plain KM; Boyd R; Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM
    Transplantation; 2007 Mar; 83(6):764-73. PubMed ID: 17414711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.